Cargando…
Targeting impulsivity in Parkinson’s disease using atomoxetine
Noradrenergic dysfunction may play a significant role in cognition in Parkinson’s disease due to the early degeneration of the locus coeruleus. Converging evidence from patient and animal studies points to the role of noradrenaline in dopaminergically insensitive aspects of the parkinsonian dysexecu...
Autores principales: | Kehagia, Angie A., Housden, Charlotte R., Regenthal, Ralf, Barker, Roger A., Müller, Ulrich, Rowe, James, Sahakian, Barbara J., Robbins, Trevor W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065022/ https://www.ncbi.nlm.nih.gov/pubmed/24893708 http://dx.doi.org/10.1093/brain/awu117 |
Ejemplares similares
-
Improving Response Inhibition in Parkinson’s Disease with Atomoxetine
por: Ye, Zheng, et al.
Publicado: (2015) -
Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures
por: Ye, Zheng, et al.
Publicado: (2016) -
Atomoxetine restores the response inhibition network in Parkinson’s disease
por: Rae, Charlotte L., et al.
Publicado: (2016) -
Locus coeruleus integrity and the effect of atomoxetine on response inhibition in Parkinson’s disease
por: O’Callaghan, Claire, et al.
Publicado: (2021) -
Selective serotonin reuptake inhibition modulates response inhibition in Parkinson’s disease
por: Ye, Zheng, et al.
Publicado: (2014)